Danwei Yu

发表

Therapeutic Efficacy and Resistance Selection of a Lipopeptide Fusion Inhibitor in Simian Immunodeficiency Virus-Infected Rhesus Macaques

C. Qin, Yuxian He, Q. Wei, 2020, Journal of Virology.

Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus

Yuxian He, Yuanmei Zhu, Hui-hui Chong, 2021, Emerging microbes & infections.

SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses

Yuxian He, Yuanmei Zhu, Hui-hui Chong, 2021, Signal Transduction and Targeted Therapy.

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2

Jincun Zhao, yang-xin fu, Haidong Tang, 2021, Cell Research.

The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors

Yuxian He, Xiaohui Ding, Yuanmei Zhu, 2019, Journal of Virology.

Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors

Yuxian He, Yuanmei Zhu, Hui-hui Chong, 2019, Viruses.

Structural and Functional Characterization of the Secondary Mutation N126K Selected by Various HIV-1 Fusion Inhibitors

Yuxian He, Xiaohui Ding, Yang Su, 2020, Viruses.

Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus

Yuxian He, Yuanmei Zhu, Hui-hui Chong, 2018, Journal of Virology.

Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial–approved membrane fusion inhibitor

Yuxian He, Xiaohui Ding, Yuanmei Zhu, 2018, The Journal of Biological Chemistry.

Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants

T. Jiao, L. Ren, Jianwei Wang, 2021, Emerging microbes & infections.

Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity

Yuxian He, Yuanmei Zhu, Hui-hui Chong, 2020, Journal of Virology.

Defective HIV-1 envelope gene promotes the evolution of the infectious strain through recombination in vitro

Yuxian He, Xiuzhu Geng, Danwei Yu, 2020, BMC Infectious Diseases.

Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity

Yusen Zhou, Yuxian He, Yan Guo, 2019, Journal of Virology.

Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals

L. Ren, Jianwei Wang, Yuxian He, 2020, Science Advances.

Mechanism of HIV-1 Resistance to an Electronically Constrained α-Helical Peptide Membrane Fusion Inhibitor

Yuxian He, Xiaohui Ding, Yuanmei Zhu, 2018, Journal of Virology.